The FDA has cleared the investigational new drug (IND) application for NPX372, a first-in-class T-cell engager (TCE) for the ...
Batch-to-batch consistency is a core factor in biological production for clinical manufacturing. Four independent NurExone ...
Multiple myeloma was once viewed as an incurable diagnosis, but Ameet Patel, MD, of Florida Cancer Specialists & Research ...
StockStory.org on MSN
BDX Q4 deep dive: Portfolio reshaping and product investments offset tariff headwinds
Medical technology company Becton, Dickinson and Company (NYSE:BDX) announced in Q4 CY2025, with sales up 1.6% year on year ...
Explore the debate surrounding animal testing as new methods may jeopardise patient safety if not properly validated.
TrumpRx launched with more than 40 medications at discounted prices after negotiations with more than a dozen drug companies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results